Ward Elizabeth A
Known title: DirectorCIK: 0001934557
Associated companies
Transaction History
| THG | ▲ Buy | Grant | 4 | $0 | 9/25/2026 | View on chart |
| THG | ▲ Buy | Grant | 4 | $0 | 6/26/2026 | View on chart |
| THG | ▲ Buy | Grant | 843 | $0 | 5/12/2026 | View on chart |
| THG | ▲ Buy | Grant | 977 | $0 | 5/14/2025 | View on chart |
| THG | ▲ Buy | Grant | 2,015 | $0 | 5/15/2024 | View on chart |
| THG | ▲ Buy | Grant | 1,246 | $0 | 5/9/2023 | View on chart |
| THG | ▲ Buy | Grant | 798 | $0 | 7/19/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Hanover Insurance (THG) Draws Attention for Growth and Valuation
Recent articles highlight Hanover Insurance as a potential growth candidate, citing strong capital allocation and a discounted valuation. These reports suggest the stock may be undervalued relative to its fundamentals. The company is currently trading near its 52-week high, with an average analyst target price of $235.88.
Hanover Insurance (THG) Draws Attention for Growth and Valuation. Recent articles highlight Hanover Insurance as a potential growth candidate, citing strong capital allocation and a discounted valuation. These reports suggest the stock may be undervalued relative to its fundamentals. The company is currently trading near its 52-week high, with an average analyst target price of $235.88.